Core Insights - Synthetic biology is recognized as the "third biotechnology revolution," following the discovery of the DNA double helix and the Human Genome Project, and is becoming a focal point in global technological competition [1] - It is predicted that 70% of future products will be derived from biological methods [1] Group 1: Industry Developments - Beijing has achieved multiple breakthroughs in synthetic biology manufacturing, with applications in biomedicine, beauty economy, chemical energy, and agriculture [1] - The synthetic biology manufacturing industry in Changping District generated over 6 billion yuan in revenue last year [6] - The Changping District has gathered over 120 synthetic biology companies, with projected revenue exceeding 6 billion yuan in 2024 and fixed asset investments surpassing 4.3 billion yuan [7] Group 2: Company Innovations - Microgen Synthetic, established in December 2021, is one of the earliest teams in China engaged in synthetic biology research and industrialization [3] - The company has developed a one-step fermentation method for producing allulose, achieving over 80% conversion rate and significantly reducing production costs [4] - The company has also established an engineering scale-up center and a small-scale flexible production base in Qinhuangdao, which are now operational [5] Group 3: Technological Advancements - Synthetic biology manufacturing addresses high energy consumption and pollution in chemical production, as well as low efficiency and high costs in agricultural planting [2] - Beijing has made significant advancements in key technologies such as carbon conversion and chassis cell design, leading to innovative products like high-efficiency DNA insertion technology and bio-based adipic acid production [8]

Core Insights - The Beijing pharmaceutical and health industry reached a scale of 1.06 trillion yuan in 2024, with a year-on-year growth of 8.7%, indicating a significant acceleration towards becoming a globally influential modern pharmaceutical and health industry cluster [1] Group 1: Industry Development - The Beijing municipal government has implemented three rounds of action plans since 2018 to accelerate collaborative innovation in the pharmaceutical and health sector, establishing a dual leadership mechanism between technology management and industry management departments [1][2] - In 2024 and 2025, Beijing introduced measures to promote high-quality development in the pharmaceutical sector, attracting eight well-known pharmaceutical companies to establish innovative entities in the city [2] Group 2: Talent and Investment - The city has initiated various talent training programs, including those for physician-scientists and young clinical research talents, to effectively cultivate urgently needed professionals in the industry [2] - A municipal-level investment fund of 20 billion yuan has been established to support innovation and development in the pharmaceutical and health sector [2] Group 3: Technological Advancements - Beijing boasts a concentration of technological resources, including universities and research institutions, which support the design and modification of microorganisms, leading to innovative outcomes in key technology areas [3] - The city has a leading clinical level with numerous national clinical research centers and medical centers, housing expert teams with extensive clinical experience [3] Group 4: Emerging Industries - Significant progress has been made in brain-machine interface and synthetic biology manufacturing, with breakthroughs in key technologies and clinical applications [4][5] - The development of innovative products, such as the world's first efficient large fragment DNA insertion technology and advanced biomanufacturing techniques, has been achieved [5] Group 5: Future Directions - Moving forward, Beijing aims to enhance policy implementation and promote innovation-driven industry development, focusing on brain-machine interfaces and synthetic biology manufacturing to foster new productive forces [6]

Group 1 - The event "Capital Academician Expert Forum" focused on "Synthetic Biology Technology Revolution and Industrial Opportunities," gathering nearly 50 academicians and experts to provide advice for the innovative development of the synthetic biology manufacturing industry in the capital [1] - Keynote speeches were delivered by prominent academicians, sharing research findings to support the transition of agricultural production in the capital towards high-quality and green development [1] - A roundtable discussion addressed current issues and challenges in synthetic biology technology, emphasizing interdisciplinary collaborative innovation and the integration of multiple technologies [1] Group 2 - Synthetic biology technology is a crucial component in accelerating the formation of new productive forces, reshaping production paradigms in agriculture, biology, medicine, energy, and environment [2] - Beijing's promotion of synthetic biology technology innovation has unique advantages in education, technology, talent, and ecology, aiming to closely integrate synthetic biology manufacturing with the cultivation of new bioeconomic dynamics [2] - The "Capital Academician Expert Forum" is organized by the Beijing Talent Work Bureau, the Chinese Academy of Sciences, and the Chinese Academy of Engineering, serving as an important platform for deepening talent integration and technology exchange [2]

Core Viewpoint - Beijing's urban sub-center aims to become an international benchmark for green economy development by focusing on ten green industries and implementing eight major tasks to promote the scale and specialization of green industries by 2027 [1][2]. Group 1: Green Industry Development - The urban sub-center plans to exceed 300 green enterprises and establish one green industry cluster by 2027, enhancing green innovation capabilities and increasing the number of effective green technology patents by approximately 20% annually [2][3]. - The focus will be on developing specialized green industries such as carbon professional services, ESG services, green finance, and synthetic biology manufacturing, while also consolidating existing green industries like renewable energy and smart connected vehicles [3][4]. Group 2: Infrastructure and Investment - The first green industry cluster, the Beijing Green Technology Innovation Service Industrial Park, is under construction and will utilize the old Beijing Optical Instrument Factory site, aiming for completion by the end of 2027 [4][5]. - The park will feature a 100% renewable energy supply system and is expected to reduce annual CO2 emissions by 1,000 tons through advanced energy management systems [4][5]. Group 3: Strategic Initiatives - Key tasks include establishing the Beijing International Green Technology Concept Verification Center, enhancing the role of local industry funds in supporting green economy initiatives, and leveraging the urban sub-center's position as a leading green finance hub [4][5].

Core Viewpoint - The establishment of a new material project in Anxiang County, Hunan, marks a significant step towards developing a non-grain raw material synthetic biology manufacturing industry, with an annual production capacity of 50,000 tons of new materials [1][3]. Group 1: Project Overview - The project focuses on producing cellulose polylactic acid (PLA) using non-grain raw materials such as reeds and straw, which are ideal for bio-manufacturing [3]. - The synthetic biology method will decompose cellulose and hemicellulose from reeds into glucose and xylose, which will then be fermented into lactic acid and polymerized into biodegradable plastics [3]. - The biodegradable plastic produced can decompose completely into carbon dioxide and water within 6 to 12 months after disposal [3]. Group 2: Market and Industry Context - The bio-based raw materials are categorized into grain-based and non-grain-based, with non-grain options like reeds offering significant advantages in cost, energy savings, and carbon reduction compared to grain-based products [3]. - Anxiang County has over 20,000 acres of reeds, primarily located along the Li River, Songzi River, and west of the Hudu River, providing a solid foundation for the synthetic biology industry [3]. - The collaboration with Shanghai Hanhe Biological New Materials Technology Co., Ltd. strengthens Anxiang County's position in the synthetic biology sector [3].

Group 1 - Lingzhu Technology has completed a multi-million yuan angel round financing from Shenzhen Innovation Investment Group and achieved mass production of recombinant spider silk protein, marking a significant milestone in the biobased materials sector [1] - The company utilizes synthetic biology technology to create a new production pathway for spider silk, which is known for its high strength and toughness, surpassing carbon fiber and ballistic materials [2] - Lingzhu Technology has developed a proprietary full-length spider silk gene library, allowing for precise design and regulation of spider silk protein structures to enhance strength, toughness, and biodegradability [2] Group 2 - The company has successfully transitioned from laboratory to factory, achieving stable mass production through microbial fermentation technology and advanced purification and spinning techniques [3] - Lingzhu plans to expand production capacity significantly over the next two years, aiming for larger-scale production by the end of 2026 to meet market demand for high-performance biobased materials [3] - Collaborations with international and domestic brands, as well as partnerships with universities, are in place to develop innovative products based on spider silk protein, covering textiles and skincare [3]

作为新质生产力的代表，合成生物学、生物制造以及生物产业，近些年，受到来自政产学研用金各 方广泛关注和重点支持，多地政府将合成生物制造产业写进工作报告。 科学家、企业家和投资家， 在产业发展中发挥着重要作用。 融行业智慧、共襄盛举 聚产业力量、擘画未来 第三届SynBio Suzhou中国合成生物学"科学家+企业家+投资家"大会 将于2025年8月1-2日在 苏州 国际博览中心 举办（同期举办 第七届CMC-China博览会 ）！ 扫码！锁定免费参会名额！ 话题将覆盖： 农业、食品与能源， 医美、医药、大健康 ， 合成生物技术、中试放大与商业化， 以 及 项目路演 等多个方面，诚邀莅临，共襄盛举！ 往期精彩： （按首字母排序，排名不分先后， 嘉宾单位或头衔为参加往期活动时信息，或有改变 ） 圆满落幕！下一站去哪？2023中国（苏州）合成生物学创新峰会成功举办 大会主办丨 Synbio深波 会议时间 | 2025年8月1-2日 会议地点 | 中国·苏州·国际博览中心B馆 扫码！锁定免费参会名额！ 往期嘉宾 阵容 2023中国(苏州)合成生物学产业技术峰会圆满落幕 合成生物，聚势苏州：2024中国合成生物学"科学家 ...